Showing results (211-220 of 229) with videos related to

Sort By:
Pageof 23
Brachytherapy|December 17, 2022
Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapyAba Anoa Scott, Madrigal Weersink, Zhihui Amy Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2017
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS TrialKyaw L Aung, Sandra E Fischer, Robert E Denroche, et al.
Radiology|September 10, 2014
MR-guided prostate biopsy for planning of focal salvage after radiation therapyCynthia Ménard, Douglas Iupati, Julia Publicover, et al.
Cancer|January 28, 2012
Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapyGaetano Zafarana, Adrian S Ishkanian, Chad A Malloff, et al.
The Lancet. Oncology|October 1, 2015
Expanding global access to radiotherapyRifat Atun, David A Jaffray, Michael B Barton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2011
NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapyJennifer A Locke, Gaetano Zafarana, Adrian S Ishkanian, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 6, 2024
Prospective evaluation of patient-reported anxiety and experiences with adaptive radiation therapy on an MR-linacAmanda Moreira, Winnie Li, Alejandro Berlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2023
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical CancerKathy Han, Jinfeng Zou, Zhen Zhao, et al.
Cancer|October 23, 2014
Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus statusShao Hui Huang, John N Waldron, Michael Milosevic, et al.
Gynecologic Oncology|January 23, 2017
A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancersKim A Reiss, Joseph M Herman, Deborah Armstrong, et al.
Pageof 23